Angelica sinensis polysaccharide nanoparticles as novel non-viral carriers for gene delivery to mesenchymal stem cells

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 9, Issue 8, 2013, Pages 1181-1191

  Deng, Wenwen ^a   Fu, Min ^a   Cao, Yue ^a   Cao, Xia ^a   Wang, Miao ^a   Yang, Yan ^a   Qu, Rui ^a   Li, Jun ^a   Xu, Ximing ^a   Yu, Jiangnan ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

Mesenchymal stem cells; Nanoparticle; Non viral vector; Polyethylenimine; Polysaccharide

Indexed keywords

LOW MOLECULAR WEIGHT; MESENCHYMAL STEM CELL; NONVIRAL VECTORS; POLYETHYLENIMINES; SEMI-QUANTITATIVE RT-PCR; SPHERICAL NANOPARTICLES; TRANSFECTION EFFICIENCY; TRANSFORMING GROWTH FACTOR BETA;

CELL CULTURE; GENE TRANSFER; GENES; MOLECULAR BIOLOGY; POLYSACCHARIDES; STEM CELLS; VECTORS;

NANOPARTICLES;

CATIONIC ANGELICA SINENSIS POLYSACCHARIDE PLASMID ENCODING TRANSFORMING GROWTH FACTOR BETA 1 NANOPARTICLE; LIPOFECTAMINE; NANOCARRIER; NANOPARTICLE; PLASMID DNA; POLYETHYLENEIMINE; POLYSACCHARIDE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANGELICA SINENSIS; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PARTICLE SIZE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZETA POTENTIAL;

ANGELICA SINENSIS; RATTUS;

MESENCHYMAL STEM CELLS; NANOPARTICLE; NON-VIRAL VECTOR; POLYETHYLENIMINE; POLYSACCHARIDE;

ANGELICA SINENSIS; ANIMALS; CELL LINE; CELLS, CULTURED; DNA; HUMANS; MESENCHYMAL STROMAL CELLS; NANOPARTICLES; PLASMIDS; POLYETHYLENEIMINE; POLYSACCHARIDES; RATS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84886414012     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2013.05.008     Document Type: Article

References (47)

1. Miao C.H., Harmeling B.R., Ziegler S.F., Yen B.C., Torgerson T., Chen L., et al. CD4+ FOXP3+ regulatory T cells confer long-term regulation of factor VIII-specific immune responses in plasmid-mediated gene therapy-treated hemophilia mice. Blood 2009, 114(19):4034-4044.
2. Pringle I., Hyde S., Gill D. Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects. Expert Opin Biol Ther 2009, 9:991-1003.
3. Dwyer R.M., Khan S., Barry F.P., O'Brien T., Kerin M.J. Advances in mesenchymal stem cell-mediated gene therapy for cancer. Stem Cell Res Ther 2010, 1(3):25.
4. Piguet F., Sondhi D., Piraud M., Fouquet F., Hackett N.R., Ahouansou O., et al. Correction of brain oligodendrocytes by AAVrh. 10 intracerebral gene therapy in metachromatic leukodystrophy mice. Hum Gene Ther 2012, 23:903-914.
5. Wolff J.A., Rozema D.B. Breaking the bonds: non-viral vectors become chemically dynamic. Mol Ther 2007, 16(1):8-15.
6. Kim D.H., Rossi J.J. Strategies for silencing human disease using RNA interference. Nat Rev Genet 2007, 8(3):173-184.
7. Wirth T., Pikkarainen J.T., Samaranayake H.D., Lehtolainen-Dalkilic P., Lesch H.P., Airenne K.J., et al. Efficient gene therapy based targeting system for the treatment of inoperable tumors. J Gene Med 2012, 14(4):221-230.
8. Kaneda Y. Development of liposomes and pseudovirions with fusion activity for efficient gene delivery. Curr Gene Ther 2011, 11(6):434-441.
9. Bowles D.E., McPhee S.W.J., Li C., Gray S.J., Samulski J.J., Camp A.S., et al. Phase 1 Gene therapy for duchenne muscular dystrophy using a translational optimized AAV vector. Mol Ther 2011, 20(2):443-455.
10. Kang E.M., Choi U., Theobald N., Linton G., Priel D.A.L., Kuhns D., et al. Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils. Blood 2010, 115(4):783-791.
11. Vile R., Russell S., Lemoine N. Cancer gene therapy: hard lessons and new courses. Gene Ther 2000, 7(1):2.
12. Heilbronn R., Weger S. Viral vectors for gene transfer: current status of gene therapeutics. Drug Deliv 2010, 197:143-170.
13. Mansouri S., Lavigne P., Corsi K., Benderdour M., Beaumont E., Fernandes J.C. Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. Eur J Pharm Biopharm 2004, 57(1):1-8.
14. Pathak A., Patnaik S., Gupta K.C. Recent trends in non-viral vector-mediated gene delivery. Biotechnol J 2009, 4(11):1559-1572.
15. Kommareddy S., Amiji M. Poly (ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery. Nanomed Nanotechnol Biol Med 2007, 3(1):32-42.
16. Santos J.L., Pandita D., Rodrigues J., Pêgo A.P., Granja P.L., Tomás H. Non-viral gene delivery to mesenchymal stem cells: methods, strategies and application in bone tissue engineering and regeneration. Curr Gene Ther 2011, 11(1):46-57.
17. Tzeng S.Y., Guerrero-Cázares H., Martinez E.E., Sunshine J.C., Quiņones-Hinojosa A., Green J.J. Non-viral gene delivery nanoparticles based on Poly (β-amino esters) for treatment of glioblastoma. Biomaterials 2011, 32:5402-5410.
18. Hoekstra D., Rejman J., Wasungu L., Shi F., Zuhorn I. Gene delivery by cationic lipids: in and out of an endosome. Biochem Soc Trans 2007, 35(1):68.
19. Zuhorn I.S., Engberts J.B.F.N., Hoekstra D. Gene delivery by cationic lipid vectors: overcoming cellular barriers. Eur Biophys J 2007, 36(4):349-362.
20. Xu F., Zhang Z., Ping Y., Li J., Kang E., Neoh K. Star-shaped cationic polymers by atom transfer radical polymerization from β-cyclodextrin cores for nonviral gene delivery. Biomacromolecules 2009, 10(2):285-293.
21. Yang C., Li H., Goh S.H., Li J. Cationic star polymers consisting of α-cyclodextrin core and oligoethylenimine arms as nonviral gene delivery vectors. Biomaterials 2007, 28(21):3245-3254.
22. Anderson D.G., Akinc A., Hossain N., Langer R. Structure/property studies of polymeric gene delivery using a library of poly (β-amino esters). Mol Ther 2005, 11(3):426-434.
23. Lv H., Zhang S., Wang B., Cui S., Yan J. Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release 2006, 114(1):100-109.
24. Holladay C., Keeney M., Greiser U., Murphy M., O'Brien T., Pandit A. A matrix reservoir for improved control of non-viral gene delivery. J Control Release 2009, 136(3):220-225.
25. Kurosaki T., Kitahara T., Fumoto S., Nishida K., Nakamura J., Niidome T., et al. Ternary complexes of pDNA, polyethylenimine, and γ-polyglutamic acid for gene delivery systems. Biomaterials 2009, 30(14):2846-2853.
26. Liu J., Jiang X., Xu L., Wang X., Hennink W.E., Zhuo R. Novel reduction-responsive cross-linked polyethylenimine derivatives by click chemistry for nonviral gene delivery. Bioconjug Chem 2010, 21:1827-1835.
27. Yu J.H., Quan J.S., Huang J., Nah J.W., Cho C.S. Degradable poly (amino ester) based on poly (ethylene glycol) dimethacrylate and polyethylenimine as a gene carrier: molecular weight of PEI affects transfection efficiency. J Mater Sci Mater Med 2009, 20(12):2501-2510.
28. Moghimi S.M., Symonds P., Murray J.C., Hunter A.C., Debska G., Szewczyk A. A two-stage poly (ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Mol Ther 2005, 11(6):990-995.
29. Godbey W.T., Wu K.K., Mikos A.G. Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J Biomed Mater Res 1999, 45(3):268-275.
30. Fischer D., Li Y., Ahlemeyer B., Krieglstein J., Kissel T. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 2003, 24(7):1121-1131.
31. Liu P.J., Hsieh W.T., Huang S.H., Liao H.F., Chiang B.H. Hematopoietic effect of water-soluble polysaccharides from Angelica sinensison mice with acute blood loss. Exp Hematol 2010, 38(6):437-445.
32. Juan J., YingJie G., AiJun N. Extraction, characterization of Angelica sinensis polysaccharides and modulatory effect of the polysaccharides and Tai Chi exercise on oxidative injury in middle-aged women subjects. Carbohyd Polym 2009, 77(2):384-388.
33. Han S.B., Lee C.W., Kang M.R., Yoon Y.D., Kang J.S., Lee K.H., et al. Pectic polysaccharide isolated from Angelica gigas Nakai inhibits melanoma cell metastasis and growth by directly preventing cell adhesion and activating host immune functions. Cancer Lett 2006, 243(2):264-273.
34. Yang T., Jia M., Meng J., Wu H., Mei Q. Immunomodulatory activity of polysaccharide isolated from Angelica sinensis. Int J Biol Macromol 2006, 39(4):179-184.
35. Chen Y., Duan J., Qian D., Guo J., Song B., Yang M. Assessment and comparison of immunoregulatory activity of four hydrosoluble fractions of Angelica sinensis in vitro on the peritoneal macrophages in ICR mice. Int Immunopharmacol 2010, 10(4):422-430.
36. Cao W., Li X.Q., Wang X., Li T., Chen X., Liu S.B., et al. Characterizations and anti-tumor activities of three acidic polysaccharides from Angelica sinensis (Oliv.) Diels. Int J Biol Macromol 2010, 46(1):115-122.
37. Lim J., Park S., Jeong C., Oh J., Kim S., Ryu C., et al. Microporation is a valuable transfection method for efficient gene delivery into human umbilical cord blood-derived mesenchymal stem cells. BMC Biotechnol 2010, 10(1):38.
38. Yang Q., Peng J., Guo Q., Huang J., Zhang L., Yao J., et al. A cartilage ECM-derived 3-D porous acellular matrix scaffold for in vivo cartilage tissue engineering with PKH26-labeled chondrogenic bone marrow-derived mesenchymal stem cells. Biomaterials 2008, 29(15):2378-2387.
39. Xu X., Capito R.M., Spector M. Delivery of plasmid IGF-1 to chondrocytes via cationized gelatin nanoparticles. J Biomed Mater Res A 2008, 84(1):73-83.
40. Wong K., Sun G., Zhang X., Dai H., Liu Y., He C., et al. PEI-g-chitosan, a novel gene delivery system with transfection efficiency comparable to polyethylenimine in vitro and after liver administration in vivo. Bioconjug Chem 2006, 17(1):152-158.
41. Suzuki M., Shinkai M., Kamihira M., Kobayashi T. Preparation and characteristics of magnetite-labelled antibody with the use of poly (ethylene glycol) derivatives. Biotechnol Appl Biochem 1995, 21(3):335-345.
42. Paul W., Sharma C. Chitosan, a drug carrier for the 21st century: a review. STP Pharma Sci 2000, 10(1):5-22.
43. Gan Q., Wang T., Cochrane C., McCarron P. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids Surf B Biointerfaces 2005, 44(2):65-73.
44. Prabha S., Zhou W.Z., Panyam J., Labhasetwar V. Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Int J Pharm 2002, 244(1):105-115.
45. Xu X., Capito R.M., Spector M. Plasmid size influences chitosan nanoparticle mediated gene transfer to chondrocytes. J Biomed Mater Res A 2008, 84A(4):1038-1048.
46. MacLaughlin F.C., Mumper R.J., Wang J., Tagliaferri J.M., Gill I., Hinchcliffe M., et al. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J Control Release 1998, 56(1):259-272.
47. Eliyahu H., Siani S., Azzam T., Domb A.J., Barenholz Y. Relationships between chemical composition, physical properties and transfection efficiency of polysaccharide-spermine conjugates. Biomaterials 2006, 27(8):1646-1655.